Wide QRS, narrow QRS: What's the difference?

Journal of the American College of Cardiology

Volumn 46, Issue 2, 2005, Pages 317-319

  Olshansky, Brian ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH; DEFIBRILLATOR; HUMAN; IMPLANTATION; NOTE; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; SURVIVAL; TREATMENT OUTCOME;

EID: 22044451728     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.04.021     Document Type: Editorial

References (18)

1. Centers for Medicaid and Medicare Services. Medicare Coverage Database. Decision Memo for Implantable Cardioverter Defibrillators (ICDs) (CAG-00157N). Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=39. Accessed May 23, 2005.
2. M.S. Wathen, P.J. DeGroot, M.O. Sweeney Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596
3. A.E. Buxton, M.O. Sweeney, M.S. Wathen QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators J Am Coll Cardiol 46 2005 310 316
4. S. Iuliano, S.G. Fisher, P.E. Karasik, R.D. Fletcher, S.N. Singh QRS duration and mortality in patients with congestive heart failure Am Heart J 143 2002 1085 1091
5. S. Gottipaty VK Krelis, F. Lu The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in chronic congestive heart failure (abstr) J Am Coll Cardiol 33 1999 145
6. J.N. Cohn, S.O. Goldstein, B.H. Greenberg A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators N Engl J Med 339 1998 1810 1816
7. H.J. Shenkman, V. Pampati, A.K. Khandelwal Congestive heart failure and QRS duration establishing prognosis study Chest 122 2002 528 534
8. S. Baldasseroni, C. Opasich, M. Gorini Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5,517 outpatients with congestive heart failure a report from the Italian network on congestive heart failure Am Heart J 143 2002 398 405
9. B. Hesse, L.A. Diaz, C.E. Snader, E.H. Blackstone, M.S. Lauer Complete bundle branch block as an independent predictor of all-cause mortality report of 7,073 patients referred for nuclear exercise testing Am J Med 110 2001 253 259
10. M.G. Shlipak, A.S. Go, P.D. Frederick, J. Malmgren, H.V. Barron, J.G. Canto Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators J Am Coll Cardiol 36 2000 706 712
11. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
12. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
13. A. Kadish, A. Dyer, J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
14. Centers for Medicaid and Medicare Services. Medicare Coverage Database. Decision Memo for Implantable Defibrillators (CAG-00157R3). Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148. Accessed May 23, 2005.
15. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
16. A.E. Buxton Risk stratification for sudden death do we need anything more than ejection fraction? Card Electrophysiol Rev 7 2003 434 437
17. M.R. Allen, R.J. Gibbons, A.R. Zinsmeister Sex differences in ventricular function in patients with right bundle branch block Am Heart J 136 1998 418 424
18. S.A.S. Kutalek, A. Hallstrom, L. Greene DAVID Investigators Soft indications for pacing in the DAVID trial do not increase mortality and heart failure admission (abstr) J Am Coll Cardiol 43 Suppl 2004 139A